معرفی
Dr. Michael Cohenuram is an Assistant Professor of Medicine (Medical Oncology) at the Yale School of Medicine, specializing in thoracic malignancies, breast cancer, and lymphoma. He practices at Smilow Cancer Hospital and the Norma Pfriem Breast Center in Bridgeport, CT. Dr. Cohenuram completed his MD at Mount Sinai School of Medicine (2000), residency at Brown Medical School/Rhode Island Hospital (2003), and fellowship at Yale Cancer Center (2008). He is actively involved in clinical trials focusing on lung, breast, and prostate cancers, serving as a sub-investigator in multiple Phase II/III studies. His research interests align with his clinical practice, emphasizing targeted therapies and immune-based treatments. Dr. Cohenuram has been consistently recognized as a Top Doc by both Castle Connolly and Connecticut Magazine. He also participates in disease-specific research teams at Yale, contributing to advancements in thoracic and breast oncology.
- Education:
- MD: Mount Sinai School of Medicine (2000)
- Residency: Brown Medical School/Rhode Island Hospital (2003)
- Fellowship: Yale Cancer Center (2008)
- Research & Clinical Trials:
- Focus areas: Lung cancer, breast cancer, lymphoma, and clinical trials evaluating novel therapies.
- Current trials include studies on pembrolizumab/brentuximab vedotin for lymphoma, osimertinib/bevacizumab for NSCLC, and prostate cancer treatment intensification.
- Awards:
- Castle Connolly Top Doc (2014–2022)
- Connecticut Magazine Top Doc (2013–2022)
- Labs/Teams: Active member of the Yale Cancer Center’s Thoracic Oncology and Breast Cancer research teams.